Pharma & HealthcareTop Companies
Pharma & Healthcare

Top Automated Cell Shaker Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Pharma & Healthcare

Published

Jan 2026

Share:

Pharma & Healthcare

Top Automated Cell Shaker Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (US$)
0.64 Billion
2026 Forecast (US$)
0.69 Billion
2032 Forecast (US$)
1.07 Billion
CAGR (2025-2032)
7.60%

Summary

The Automated Cell Shaker market is entering a consolidation-driven growth phase, underpinned by bioprocess efficiency, safety, and reproducibility demands. Leading Automated Cell Shaker market companies leverage integrated automation, data connectivity, and GMP-compliant design to capture share. With global revenues projected to reach US$ 1.07 Billion by 2032, the sector is set to expand at a 7.60% CAGR.

2025 Revenue of Top Automated Cell Shaker Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

The ranking of Automated Cell Shaker market companies is based on a composite score blending quantitative and qualitative indicators. Core metrics include 2025 Automated Cell Shaker revenue, three-year segment growth, order backlog, and installed base across biopharma, CRO, and academic customers. We further evaluate technology differentiation, such as integration with incubators, CO2 control, data interfaces, and robotic handling. Portfolio breadth, covering benchtop and high-throughput systems, as well as compliance with GMP and 21 CFR Part 11, significantly influence scores. Service coverage is assessed through global footprint, validation support, training, and long-term maintenance contracts. Lastly, strategic moves—including M&A, OEM alliances, and digital offerings—are reviewed. Each company receives normalized scores across dimensions, which are weighted and aggregated to determine final rankings.

Top 10 Companies in Automated Cell Shaker

1
Thermo Fisher Scientific Inc.
Waltham, USA
North America, Europe, Asia Pacific
Approx. 130,000
Precision motion control, connectivity to LIMS/MES, CO2 and humidity integration, remote monitoring
US$ 0.12 Billion (Automated Cell Shakers, estimated)
Integrated automated shakers for incubators, high-throughput screening, and GMP-compliant bioprocessing platforms
Expanded automation alliances with major biopharma CDMOs; invested in digital workflow integration and analytics
2
Eppendorf SE
Hamburg, Germany
Europe, North America, China
Approx. 5,000
Gentle mixing drives, temperature uniformity, intuitive touch interfaces, programmable profiles
US$ 0.09 Billion (Automated Cell Shakers, estimated)
Benchtop and stackable automated shakers for cell culture, microbiology, and process development
Launched energy-efficient shaker line; expanded service contracts targeting GMP-compliant bioprocess labs
3
Sartorius AG
Göttingen, Germany
Europe, North America, Asia Pacific biopharma clusters
Approx. 14,000
Advanced process control, PAT integration, single-use compatibility, data-rich monitoring
US$ 0.08 Billion (Automated Cell Shakers, estimated)
Automated shakers integrated with single-use bioreactors and cell line development platforms
Strengthened partnerships with CDMOs; integrated shaker data into bioprocess control software suite
4
Agilent Technologies Inc.
Santa Clara, USA
North America, Europe, Japan
Approx. 18,000
Workflow automation, seamless instrument integration, cloud-based data management
US$ 0.06 Billion (Automated Cell Shakers, estimated)
Automated shakers paired with cell analysis and high-content screening systems
Acquired niche automation IP; launched connectivity upgrades for pharma and CRO customers
5
Hamilton Company
Reno, USA / Bonaduz, Switzerland
North America, Western Europe
Approx. 3,500
Robotic deck integration, precision liquid handling, scalable automation platforms
US$ 0.05 Billion (Automated Cell Shakers, estimated)
Robotics-integrated automated shakers for high-throughput screening and sample preparation
Expanded OEM shaker modules; targeted cell therapy workflows with configurable automation cells
6
INFORS HT
Bottmingen, Switzerland
Europe, North America, selected Asia Pacific markets
Approx. 500
Versatile platform design, advanced control software, modular upgrades
US$ 0.04 Billion (Automated Cell Shakers, estimated)
Specialized shakers and bioreactors for microbial and mammalian cell culture
Introduced digital twin-enabled control; strengthened distributor network in high-growth Asian markets
7
New Brunswick (Eppendorf brand)
Enfield, USA
North America, Europe, Latin America
Part of Eppendorf SE
Robust drive systems, high-capacity platforms, programmable agitation profiles
US$ 0.04 Billion (Automated Cell Shakers, estimated)
Incubator shakers and large-capacity systems for fermentation and cell culture
Refreshed legacy lines with digital controls; targeted retrofit opportunities in academic institutions
8
Kuhner Shaker AG
Birsfelden, Switzerland
Europe, Asia, North America niche segments
Approx. 150
Highly stable motion, low-vibration design, custom platform options
US$ 0.03 Billion (Automated Cell Shakers, estimated)
Premium orbital shakers and incubation systems for R&D and pilot-scale applications
Expanded customized solutions; focused on biopharma and vaccine manufacturing clients
9
Benchmark Scientific Inc.
Sayreville, USA
North America, Latin America, emerging Asia
Approx. 200
User-friendly controls, versatile platforms, cost-efficient designs
US$ 0.02 Billion (Automated Cell Shakers, estimated)
Compact and mid-range shakers for academic and routine laboratories
Launched entry-level incubated shaker series; strengthened e-commerce and distributor channels
10
Labnet International, Inc.
Edison, USA
North America, Europe, Asia-Pacific distributors
Approx. 150
Compact footprints, digital timers, variable speed and orbit
US$ 0.02 Billion (Automated Cell Shakers, estimated)
General-purpose laboratory shakers with automated programming options
Introduced upgraded control interfaces; expanded OEM partnerships targeting regional lab equipment brands

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific delivers comprehensive automated cell shaking solutions integrated into incubators, bioprocess platforms, and digital laboratory ecosystems worldwide.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.12 Billion; segment growth 8.20% CAGR 2025-2032 (estimated).
Flagship Products: Heracell VIOS Shaker Series, Cytomat Incubator-Shaker Platforms, Thermo Scientific MaxQ HP
2025-2026 Actions: Deepened CDMO partnerships, launched enhanced connectivity and cloud-based monitoring for automated shakers.
Three-line SWOT: Strong brand and global service network; Complex portfolio can slow product refresh cycles; Opportunity—biologics and cell therapy expansion in emerging markets.
Notable Customers: Pfizer, Lonza, Novartis
2

Eppendorf SE

Eppendorf SE is a leading provider of benchtop and stackable automated shakers catering to cell culture, microbiology, and process development labs.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.09 Billion; operating margin 16.40% (estimated for segment).
Flagship Products: New Brunswick Excella Shakers, Innova Shaker Series, Eppendorf Innova S44i
2025-2026 Actions: Rolled out energy-efficient shaker line and expanded global GMP-compliant service contracts.
Three-line SWOT: Strong presence in academic and bioprocess labs; Limited ultra-high-throughput automation portfolio; Opportunity—energy-efficient systems demanded by sustainability-focused facilities.
Notable Customers: Roche, DSM, University of Cambridge
3

Sartorius AG

Sartorius AG integrates automated cell shakers with single-use bioreactors and advanced bioprocess control platforms for biopharma manufacturers.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.08 Billion; R&D spend approximately 9.50% of segment sales.
Flagship Products: Sartorius Cell Growth Shaker Platforms, BIOSTAT Shaker-Integrated Systems, ambr Shaker Modules
2025-2026 Actions: Linked shaker data into PAT and control suites; enhanced offerings for cell line development workflows.
Three-line SWOT: Deep bioprocess expertise and software integration; Premium pricing limits penetration in cost-sensitive labs; Opportunity—single-use and PAT adoption in emerging bioclusters.
Notable Customers: Boehringer Ingelheim, WuXi Biologics, Sanofi
4

Agilent Technologies Inc.

Agilent Technologies offers automated shakers embedded within cell analysis and high-content screening workflows for pharma and CRO customers.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.06 Billion; segment growth 7.80% year-on-year.
Flagship Products: Agilent BioTek Automated Shaker Modules, Agilent Cell Analysis Shaker Platforms, Bravo-compatible Shaker Units
2025-2026 Actions: Enhanced integration between shaker modules and analytics platforms; pursued acquisitions in automation technologies.
Three-line SWOT: Strong analytics and workflow integration capabilities; Smaller installed base in routine labs; Opportunity—CRO outsourcing and complex assay automation demand.
Notable Customers: Charles River Laboratories, AstraZeneca, Takeda
5

Hamilton Company

Hamilton Company specializes in robotics-integrated automated cell shakers supporting high-throughput screening, sample preparation, and cell therapy workflows.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.05 Billion; robotics-linked sales share above 70.00%.
Flagship Products: Hamilton Microlab STAR Shaker Decks, VANTAGE Integrated Shaker Modules, Hamilton Cell Workstation Shakers
2025-2026 Actions: Developed configurable automation cells specifically for cell therapy and gene therapy applications.
Three-line SWOT: Strong robotics integration and customization; High capital costs reduce appeal for small labs; Opportunity—scaling cell and gene therapy manufacturing automation.
Notable Customers: Regeneron, Gilead, academic cell therapy centers
6

INFORS HT

INFORS HT focuses on specialized shakers and bioreactors designed for microbial and mammalian culture, emphasizing flexibility and digital control.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.04 Billion; export share approximately 80.00%.
Flagship Products: INFORS HT Multitron, Ecotron Shakers, Minitron Incubator Shakers
2025-2026 Actions: Launched digital twin-ready control software and broadened distribution in Asia.
Three-line SWOT: High-quality engineering and flexible platforms; Smaller scale than global conglomerates; Opportunity—niche bioprocess optimization projects needing tailored solutions.
Notable Customers: Merck KGaA, public research institutes, vaccine manufacturers
7

New Brunswick (Eppendorf brand)

New Brunswick, an Eppendorf brand, delivers robust incubator shakers and large-capacity systems for fermentation and cell culture labs.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.04 Billion; legacy installed base exceeding 20,000 units worldwide.
Flagship Products: New Brunswick Innova Incubator Shakers, New Brunswick Classic Series, New Brunswick BioFlo Shaker-Integrated Systems
2025-2026 Actions: Upgraded legacy platforms with digital controls and remote monitoring capabilities.
Three-line SWOT: Strong installed base and brand loyalty; Some legacy models energy-intensive; Opportunity—retrofit and modernization programs at universities and biopharma sites.
Notable Customers: AbbVie, global universities, regional bioprocess labs
8

Kuhner Shaker AG

Kuhner Shaker AG provides premium orbital shakers and incubation systems built for reliability in demanding R&D and pilot-scale operations.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.03 Billion; high-end product mix supports strong gross margins.
Flagship Products: Kuhner ISF1-X Shaker, Kuhner LT-X, Kuhner Kelvin Incubator Shakers
2025-2026 Actions: Expanded customized shaker platforms for vaccine and enzyme production applications.
Three-line SWOT: Excellent motion stability and durability; Limited presence in entry-level segments; Opportunity—growth in quality-focused biopharma and vaccine projects.
Notable Customers: GlaxoSmithKline, Novozymes, European research centers
9

Benchmark Scientific Inc.

Benchmark Scientific supplies compact and mid-range shakers targeting academic, clinical, and routine laboratory users seeking affordable automation.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.02 Billion; revenue concentration 65.00% in North America.
Flagship Products: Benchmark Incu-Shaker Series, Orbi-Shaker XL, BenchMark BT300 Shakers
2025-2026 Actions: Introduced new incubated shaker models and strengthened distributor-led sales channels.
Three-line SWOT: Competitive pricing and user-friendly designs; Limited high-end automation capabilities; Opportunity—rising equipment demand from teaching and regional diagnostic labs.
Notable Customers: State universities, regional hospitals, contract testing labs
10

Labnet International, Inc.

Labnet International offers general-purpose shakers with automated programming options for routine life science and industrial laboratories.

Key Financials: 2025 Automated Cell Shaker revenue US$ 0.02 Billion; double-digit growth in Asia-Pacific distributor sales.
Flagship Products: Labnet Orbit Shaker Series, Labnet 311DS, VorTemp Shaker-Incubator
2025-2026 Actions: Refreshed control interfaces and expanded OEM collaborations with regional brands.
Three-line SWOT: Broad basic portfolio and strong distributor relationships; Limited brand recognition in top-tier biopharma; Opportunity—OEM partnerships in fast-growing emerging markets.
Notable Customers: Regional lab chains, OEM label partners, teaching labs

SWOT Leaders

Thermo Fisher Scientific Inc.

SWOT Snapshot

SWOT
Strengths

Extensive global footprint, broad portfolio, strong integration with incubators and digital lab platforms.

Weaknesses

Complex product ecosystem can lengthen qualification cycles and implementation in regulated facilities.

Opportunities

Rising biologics and cell therapy investments, especially in Asia and emerging bioclusters.

Threats

Intensifying competition from specialized mid-tier vendors and price-sensitive tenders in developing markets.

Eppendorf SE

SWOT Snapshot

SWOT
Strengths

Trusted brand in academia and bioprocess, strong service network, energy-efficient and ergonomic designs.

Weaknesses

Less exposure to ultra-high-throughput and fully robotic integrated lines.

Opportunities

Replacement of aging shaker fleets and sustainability-driven upgrades across global lab networks.

Threats

Aggressive pricing from low-cost Asian manufacturers and currency volatility impacting export margins.

Sartorius AG

SWOT Snapshot

SWOT
Strengths

Deep bioprocess integration, strong software and PAT capabilities, alignment with single-use manufacturing.

Weaknesses

Premium pricing and complex solutions can deter smaller institutions and start-ups.

Opportunities

Expansion of biologics pipelines and regulatory emphasis on process analytical technology.

Threats

Macroeconomic slowdowns delaying capex decisions and competition from integrated bioprocess platform rivals.

Automated Cell Shaker Market Regional Competitive Landscape

North America remains the largest and most technologically advanced region, driven by strong biopharma pipelines, NIH-funded research, and expanding CDMOs. Thermo Fisher Scientific, Agilent Technologies, and Hamilton Company anchor the region, while mid-tier Automated Cell Shaker market companies such as Benchmark Scientific and Labnet capture growth in academic and clinical labs.

Europe shows a balanced mix of innovation and regulatory rigor, with Germany and Switzerland hosting leading Automated Cell Shaker market companies including Eppendorf SE, Sartorius AG, INFORS HT, and Kuhner Shaker AG. EU GMP requirements and energy-efficiency targets are accelerating replacement cycles, particularly across biologics, vaccine manufacturing, and public research institutes.

Asia Pacific is the fastest-growing region, underpinned by large-scale investments in biologics, biosimilars, and cell therapy infrastructure in China, South Korea, India, and Singapore. Global Automated Cell Shaker market companies expand via local manufacturing, partnerships, and technical centers, balancing premium imported systems with more cost-sensitive offerings for domestic institutions.

Latin America and the Middle East & Africa represent smaller but steadily expanding markets, primarily focused on upgrading public health labs and regional vaccine production capabilities. Automated Cell Shaker market companies leverage distributors and OEM partnerships, with brands like New Brunswick, Eppendorf, and Labnet gaining traction through competitively priced, robust systems and training-focused deployments.

In Japan and developed Asia, automation density is high, with strong demand for reliability, compact footprints, and seamless integration into existing robotic lines. Automated Cell Shaker market companies such as Thermo Fisher Scientific, Agilent, and Sartorius succeed by offering localized service, multilingual software interfaces, and compliance with region-specific standards and data regulations.

Automated Cell Shaker Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

CellMotion Robotics
Disruptor
USA

Develops modular robotic platforms with integrated automated shakers optimized for cell therapy manufacturing suites and closed, aseptic workflows.

ShakoBio Technologies
Disruptor
South Korea

Offers compact, IoT-enabled incubator shakers with real-time vibration diagnostics and cloud analytics for small biotechs and university labs.

VibraSense Labs
Disruptor
Germany

Focuses on ultra-low-vibration shaker designs that protect sensitive stem cell and organoid cultures while capturing detailed motion data.

OrbitX Lifesciences
Disruptor
India

Targets cost-sensitive emerging markets with robust automated shakers featuring localized manufacturing and remote service capabilities.

BioFlow AI Systems
Disruptor
Belgium

Integrates AI-driven motion profiles and adaptive control to optimize cell growth conditions dynamically across multi-shaker installations.

Automated Cell Shaker Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Automated Cell Shaker market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Automated Cell Shakermarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.